- President Biden today is expected to increase his goal of COVID-19 shots administered in his first 100 days in office from 100M to 200M doses, according to CNBC.
- The U.S. reached 100M doses administered last week on Biden's 59th day in office.
- The U.S. has been averaging about 2.5M doses administered per day over the last week.
- The U.S. government is expecting Johnson & Johnson (NYSE:JNJ) to deliver 300M doses.
- In addition, a combination of 600M doses is expected from Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX).
- J&J is down 0.3% to $161.43, Moderna is down 0.2% to $131.34, Pfizer is down 0.8% to $35.34, and BioNTech is up 0.7% to $94.73 in morning trading.